REWINE PHARMACEUTICAL
Daclatasvir 60mg Tablets

Daclatasvir 60mg Tablets

Send Inquiry
Daclatasvir 60mg Tablets
 
Daclatasvir is indicated for use, with sofosbuvir, with or without ribavirin for the treatment of patients with chronic HCV genotype 1 or 3. The use of ribavirin depends on the patient population treated as outlined below. For patients with HCV/HIV-1 coinfection, the dosage and duration are the same as listed below.